Ministry of Education
Abhimanyu Dev
VIDWAN ID: 404886

Dr Abhimanyu Dev

Male Doctor of Philosophy
Assistant Professor | Department of Pharmaceutical Sciences and Technology
Birla Institute of Technology, Ranchi
Jharkhand
Expertise: Miscellaneous Biology
ORCID 0000-0001-7034-6021 Scopus 36522668900 ResearcherID AAJ-6767-2020 Google Scholar TQZQkSgAAAAJ
View older version My Dashboard
38 Publications
6 Projects
905 Scopus Citations
770 CrossRef
21 Years 11 Months Total Experience
Publications
38 Total
Articles
35
Books
1
Chapters
2
Activity

No publication activity to display.

Scopus Scopus
905 Citations
15 h-index
CrossRef CrossRef
770 Citations
15 h-index
Google Scholar Google Scholar

Loading Scholar statistics...

Professional Recognition

No Data Found

There is currently nothing to display here.

Community & Membership

No Data Found

There is currently nothing to display here.

Association of Pharmaceutical Teachers in India (APTI)
Life Member
Association of Microbiology of India (AMI)
Life Member

Personal Details

Doctor of Philosophy
2013
Central Institute of Mining and Fuel Research
Assistant Professor
Jun 2007 – Present
Birla Institute of Technology, Ranchi | Department of Pharmaceutical Sciences and Technology
Lecturer
Aug 2005 – Jun 2007
Royal College of Pharmacy and Health Sciences (RCPHS), Berhampur
Research Scholar
Aug 2004 – May 2005
ICAR-Directorate of Weed Research
Biological Sciences
Miscellaneous Biology

Related Profiles

Scholarly Work

Development of dual functionalized carbogenic nanocarrier for active targeting of CD44 and αvβ3 integrin receptors in breast cancer
Other
Agency: Indian Council of Medical Research Role: Principal Investigator
Amount: ₹13.20 Lac
Duration: 2022 – Ongoing
Aptamer-based Rapid Diagnostic Kit for Detection of Corona Virus Infection (CoVapt
Completed
Agency: Department of Science and Technology Role: Principal Investigator
Amount: ₹15.75 Lac
Duration: 2020 – 2021
Development of multi-functional nano-HAP bone substitute for effective bone regeneration in critical defects
Completed
Agency: Department of Science and Technology Role: Co-Principal Investigator
Amount: ₹1.13 Crore
Duration: 2019 – 2022
Phenyloxazoline Synthetase Inhibitors as Antitubercular Agents (POSIAA
Completed
Agency: Department of Science and Technology Role: Co-Principal Investigator
Amount: ₹53.73 Lac
Duration: 2016 – 2019
Insilico design, synthesis and evaluation of novel azoles as HIV-1-RT inhibitors
Completed
Agency: University Grants Commission Role: Co-Principal Investigator
Amount: ₹13.84 Lac
Duration: 2013 – 2016
Formulation and characterization of multiparticulate pulsatile delivery of methotrexate based on chronotherapy for rheumatoid arthritis and it’s in vitro studies
Completed
Agency: University Grants Commission Role: Principal Investigator
Amount: ₹1.50 Lac
Duration: 2009 – 2011
No Data Found

There is currently nothing to display here.

AN APTAMER BASED DIAGNOSIS OF COVID 19 INFECTION AND METHOD THEREOF

Birla Institute of Technology Mesra
- Application No. : 202231027666 A Filed : 13-05-2022
Published : 09-09-2022 Published

Scholarly Publications

Signalling and molecular pathways, overexpressed receptors of colorectal cancer and effective therapeutic targeting using biogenic silver nanoparticles

Journal Article
Gene. Year: 2025. Volume: 936 , Pages: 149099 .
Authors: Dey, Sandip; Ghosh, Manik; Dev, Abhimanyu
DOI 10.1016/J.GENE.2024.149099 Crossref Crossref: 5 Scopus Scopus: 5

Correction to: Pluronic-Coated Biogenic Gold Nanoparticles for Colon Delivery of 5-Fluorouracil: In vitro and Ex vivo Studies (AAPS PharmSciTech, (2021), 22, 2, (64), 10.1208/s12249-021-01922-1)

Open Access
Erratum
AAPS PharmSciTech. Year: 2021. Volume: 22 , Issue: 3 .
Authors: Wael A. Mahdi; Afzal Hussain; Mohd Ramzan; Abdul Faruk; Sarah I. Bukhari; Abhimanyu Dev
DOI 10.1208/s12249-021-01954-7 Crossref Crossref: 2 Scopus Scopus: 2

An Overview on Nanoparticulate Drug Delivery System for its Specific and Targeted Effects in Various Diseases

Book Chapter
Year: 2022. Pages: 55-92 .
Scopus Scopus: 5

Carbon quantum dots: A promising nanocarrier for bioimaging and drug delivery in cancer

Review
Materials Today Communications. Year: 2022. Volume: 32 .
Authors: Pradip Jana; Abhimanyu Dev
DOI 10.1016/j.mtcomm.2022.104068 Crossref Crossref: 84 Scopus Scopus: 117

Optimization and assessment of three generation solid dispersion for enhancement of solubility and dissolution for montelukast sodium

Journal Article
Drug Development and Industrial Pharmacy. Year: 2025. Volume: 51 , Issue: 5 , Pages: 409-418 .
Authors: Kirti Rashmi; Kaushiki Ash; Abhimanyu Dev
DOI 10.1080/03639045.2025.2477722

Harnessing nanotechnology in HIV therapy: Exploring molecular pathogenesis and treatment strategies with special reference to chemotherapy and immunotherapy

Review
Microbial Pathogenesis. Year: 2025. Volume: 204 .
Authors: Kaushiki Ash; Abhimanyu Dev
DOI 10.1016/j.micpath.2025.107625

Advanced disease-responsive materials as intelligent drug delivery systems for rheumatoid arthritis

Review
Journal of Drug Delivery Science and Technology. Year: 2026. Volume: 115 .
Authors: Shuvadip Bhowmik; Rashmi Ghosh; Abhimanyu Dev
DOI 10.1016/j.jddst.2025.107787 Crossref Crossref: 1 Scopus Scopus: 5

Co-delivery of dolutegravir and carbon-nanoparticles using niosomal platform for enhanced anti-HIV and pharmacokinetic activity

Journal Article
European Journal of Pharmaceutics and Biopharmaceutics. Year: 2026. Volume: 219 .
Authors: Kaushiki Ash; R Harshithkumar; Madhuri Chandane-Tak; Anupam Mukherjee; Ashok Pattnaik; Satyajit Mohanty; Monika Dwivedi; Abhimanyu Dev
DOI 10.1016/j.ejpb.2025.114963
Showing 1 to 8 of 38 publications